We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Trump's Approval Rises Before Midterms: ETFs to Lose/Gain
Read MoreHide Full Article
With midterm elections knocking at the door, recent polls show Trump gaining popularity and even surpassing Obama's approval rating taken in late October 2010. Per NBC/Wall Street Journal poll, Trump's approval rating is now at the highest at 47% against Obama’s 45% around four years back.
Trump’s polling average on RealClearPolitics has risen from below 41% earlier this month to 44.2% at the moment. Also, the polls show 90% approval rating for Trump from the Republicans.
Overall, the polls put up Democrats with a 9-point lead over Republicans for the congressional control. About 50% of likely voters want Congress to have a Democratic bent while 41% want the status quo or Republicans to maintain the majority.
The upcoming midterm elections scheduled on Nov 6 are expected to result in a split government at Capitol Hill with Democrats winning back the House and the Republicans managing a limited hold on the Senate, per CNBC.
Although Democrats are likely to win, with the recent improvement in Trump’s approval rating, GOP leaders expect to lower the number of seats they would miss, per analysts. This will enable GOP to keep their advantage in the chamber.
And if it happens, Trump-friendly policies should be in favorable positions.
Likely Winners
Pharma to Blossom
Trump’s announcement of the drug plans in May was in the best interest of pharma companies. The drug plans will likely put pressure on U.S. trading partners, forcing them to pay more for medicines. So, the immediate impact should be positive on pharma ETFs like Invesco Dynamic Pharmaceuticals ETFPJP (read: Pharma & Biotech ETFs Soar on Trump's Drug Plan).
Regional Banks to Perform Better
Historically, financial stocks have performed better with Republicans in the White House, courtesy of tolerant policies. Plus, the Congress approved a plan on May 22 to scale down stringent banking regulations or the Dodd-Franck act undertaken in the height of the 2008 financial crisis.
Trump is in favor of beefing up public spending by hundreds of billions of dollars on infrastructure. Thus, Utilities ETFs like FirstTrust Utilities AlphaDEX Fund (FXU - Free Report) or construction ETFs like Invesco Dynamic Building & Construction Portfolio ETF (PKB - Free Report) are likely to benefit from this trend.
Defense is Now a Safe Bet
Even if there is a divided government, any major fiscal tightening is improbable in aerospace and defense stocks, despite Democrats' pledging to roll back the Trump tax cuts passed in late 2017, per an article published on CNBC. Also, Trump appears aggressive in foreign policy and signed the $717-billion 2019 defense spending bill into law — the largest allotted to U.S. defense ion August. So, defense and aerospace ETFs like iShares US Aerospace & Defense (ITA - Free Report) ) should trade healthy (read: Must-Have Aerospace and Defense ETFs & Stocks).
Likely Loser
Trade Tensions Likely to Loom
Trump’s popularity gain hints at the continuation of the trade war with China. Goldman Sachs believes that “the President's veto power and the lack of political consensus regarding appropriate trade policy reduce the likelihood that either Democrats or Republicans enact legislation that will resolve the ongoing trade tensions." So, China ETFs like iShares China Large-Cap ETF (FXI - Free Report) may be vulnerable at the moment.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Trump's Approval Rises Before Midterms: ETFs to Lose/Gain
With midterm elections knocking at the door, recent polls show Trump gaining popularity and even surpassing Obama's approval rating taken in late October 2010. Per NBC/Wall Street Journal poll, Trump's approval rating is now at the highest at 47% against Obama’s 45% around four years back.
Trump’s polling average on RealClearPolitics has risen from below 41% earlier this month to 44.2% at the moment. Also, the polls show 90% approval rating for Trump from the Republicans.
Overall, the polls put up Democrats with a 9-point lead over Republicans for the congressional control. About 50% of likely voters want Congress to have a Democratic bent while 41% want the status quo or Republicans to maintain the majority.
The upcoming midterm elections scheduled on Nov 6 are expected to result in a split government at Capitol Hill with Democrats winning back the House and the Republicans managing a limited hold on the Senate, per CNBC.
Although Democrats are likely to win, with the recent improvement in Trump’s approval rating, GOP leaders expect to lower the number of seats they would miss, per analysts. This will enable GOP to keep their advantage in the chamber.
And if it happens, Trump-friendly policies should be in favorable positions.
Likely Winners
Pharma to Blossom
Trump’s announcement of the drug plans in May was in the best interest of pharma companies. The drug plans will likely put pressure on U.S. trading partners, forcing them to pay more for medicines. So, the immediate impact should be positive on pharma ETFs like Invesco Dynamic Pharmaceuticals ETF PJP (read: Pharma & Biotech ETFs Soar on Trump's Drug Plan).
Regional Banks to Perform Better
Historically, financial stocks have performed better with Republicans in the White House, courtesy of tolerant policies. Plus, the Congress approved a plan on May 22 to scale down stringent banking regulations or the Dodd-Franck act undertaken in the height of the 2008 financial crisis.
While the move sounds great for the entire banking industry, small-cap banks should actually celebrate. The bill lowers federal oversight of banks between $50 billion and $250 billion in assets, and “eases lending, capital and trading rules for smaller lenders.” So, SPDR S&P Regional Banking ETF (KRE - Free Report) could be a lucrative choice (read: Reginal Bank ETFs & Stocks to Party on Dodd-Frank Easing).
Bet Big on Infrastructure & Utility
Trump is in favor of beefing up public spending by hundreds of billions of dollars on infrastructure. Thus, Utilities ETFs like First Trust Utilities AlphaDEX Fund (FXU - Free Report) or construction ETFs like Invesco Dynamic Building & Construction Portfolio ETF (PKB - Free Report) are likely to benefit from this trend.
Defense is Now a Safe Bet
Even if there is a divided government, any major fiscal tightening is improbable in aerospace and defense stocks, despite Democrats' pledging to roll back the Trump tax cuts passed in late 2017, per an article published on CNBC. Also, Trump appears aggressive in foreign policy and signed the $717-billion 2019 defense spending bill into law — the largest allotted to U.S. defense ion August. So, defense and aerospace ETFs like iShares US Aerospace & Defense (ITA - Free Report) ) should trade healthy (read: Must-Have Aerospace and Defense ETFs & Stocks).
Likely Loser
Trade Tensions Likely to Loom
Trump’s popularity gain hints at the continuation of the trade war with China. Goldman Sachs believes that “the President's veto power and the lack of political consensus regarding appropriate trade policy reduce the likelihood that either Democrats or Republicans enact legislation that will resolve the ongoing trade tensions." So, China ETFs like iShares China Large-Cap ETF (FXI - Free Report) may be vulnerable at the moment.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>